Search

Compugen Ltd

Uždarymo kaina

2.31 -3.35

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.29

Max

2.4

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.263

68.51

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+107.47% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

5.66

Ankstesnė uždarymo kaina

2.31

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-10 23:56; UTC

RingCentral Inc. shares advanced in after-market trading, continuing a month-long upward trend and remaining significantly above the 20-day moving average.

2026-08-10 23:56; UTC

Aramark shares are higher in after-market trading, recovering from an early decline. The stock remains below its 20-day moving average.

2026-08-10 23:56; UTC

Vir Biotechnology Inc. shares advanced in after-market trading, reflecting a modest increase from Monday's close, though still below the 20-day moving average.

2026-08-10 23:56; UTC

CF Industries Holdings Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

2026-08-10 23:56; UTC

Yelp Inc. shares rose slightly in after-market trading, despite being below the 20-day moving average and near the lower end of their one-month range.

2026-08-10 23:56; UTC

NN Inc shares are higher in after-market trading, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

2026-08-10 23:56; UTC

Johnson Controls International PLC shares are higher in after-market trading, reflecting a modest uptick following Monday's close. The stock remains above its 20-day moving average.

2026-08-10 23:56; UTC

B&G Foods Inc. shares are lower in after-market trading, reflecting broader market declines and cautious sentiment following recent labor market data.

2026-08-10 23:56; UTC

Dynatrace Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is influenced by recent economic data.

2026-08-10 23:56; UTC

New Fortress Energy shares are higher in after-market trading, reaching 2.94% above Monday's close, significantly above the 20-day moving average.

2026-08-10 23:56; UTC

Social Media

NetApp Inc shares are trading higher in after-market hours following an upgrade from Morgan Stanley, driven by increased demand for storage solutions.

2026-08-10 23:56; UTC

Ardelyx Inc shares are higher in after-market trading, despite no specific news driving the move. Recent market conditions include cautious optimism following a jobs report.

2026-08-10 23:56; UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

2026-08-10 23:56; UTC

Target Corp shares declined in after-market trading, reflecting a directional move since Monday's close. The stock remains above its 20-day moving average.

2026-08-10 23:56; UTC

Correlated Moves

Host Hotels & Resorts Inc. is trading lower in after-market hours, reflecting broader declines in small-cap stocks and cautious market sentiment following a recent jobs report.

2026-08-10 23:56; UTC

Correlated Moves
ETF Constituents

Financial Select Sector SPDR Fund declines in after-market trading as top holdings Visa, FIS, and PayPal post losses amid flat U.S. markets.

2026-08-10 23:56; UTC

Enovix Corp shares are higher in after-market trading, showing strength above their 20-day moving average amid cautious market optimism following recent labor data.

2026-08-10 23:56; UTC

Correlated Moves

indie Semiconductor Inc's shares are lower in after-market hours, influenced by broader market caution and a decline in the Russell 2000 Index.

2026-08-10 23:56; UTC

Hawaiian Electric Industries shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

2026-08-10 23:56; UTC

Quantumscape Corp shares traded lower in after-market hours, with no specific news identified. The stock remains above its 20-day moving average.

2026-08-10 23:56; UTC

Tower Semiconductor shares are higher in after-market hours, with no specific news identified. The stock remains well above its 20-day moving average.

2026-08-10 23:56; UTC

Correlated Moves

US 5Y Treasury Bond Index trades roughly flat as traders reassess September rate hike odds after a jobs report showed a decline of 23,000 jobs.

2026-08-10 23:56; UTC

Correlated Moves

US 10Y Treasury Bond Index trades near unchanged as traders reassess September rate hike odds following a jobs report indicating a decline of 23,000 jobs.

2026-08-10 23:52; UTC

Sarepta Therapeutics shares are lower in after-market hours, with no specific news identified for the decline amid broader market sentiment influenced by labor report data.

2026-08-10 23:52; UTC

Correlated Moves
ETF Constituents
Macro News
Social Media

Energy Select Sector SPDR Fund lower in after-market hours despite crude oil prices rising to $82.25 amid concerns over the Strait of Hormuz reopening.

2026-08-10 23:52; UTC

Event
News
Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

2026-08-10 23:51; UTC

Modine Manufacturing Co shares are higher in after-market trading, buoyed by last Friday's labor report that reduced expectations for Federal Reserve rate hikes.

2026-08-10 23:51; UTC

Correlated Moves

Stanley Black & Decker Inc shares declined in after-market trading amid weak market performance and downward pressure from recent labor market data.

2026-08-10 23:51; UTC

Shoals Technologies Group Inc shares are lower in after-market trading. Broader market sentiment is affected by a recent labor report and Fed rate hike expectations.

2026-08-10 23:51; UTC

Hilltop Holdings Inc is trading lower in after-market hours, continuing a decline since Monday's close amid broader market sentiment influenced by a weak labor report.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

107.47% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  107.47%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat